Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab
Home » Resources » Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab
Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab
Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab2021-05-132021-09-20/wp-content/uploads/2022/02/canopy-logo-2022-white.pngCanopy Biosciences/wp-content/uploads/2022/02/canopy-logo-2022-white.png200px200px
